BioCentury | May 23, 2016
Finance

Venturing west

...Potenza Therapeutics Inc. and autoimmune company Kanyos Bio Inc. Astellas spinouts include nocturia therapeutic developer Tacurion Pharma Inc....
BioCentury | Jun 17, 2013
Strategy

Externalizing Astellas

...spinouts of clinical assets. In May, Astellas and Drais Pharmaceuticals Inc. formed the virtual company Tacurion Pharma Inc....
...Inc. (NASDAQ:REGN), Tarrytown, N.J. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Seldar Pharma Inc. , Bridgewater, N.J. Tacurion Pharma Inc....
BioCentury | May 13, 2013
Company News

Drais, Tacurion, Astellas deal

...Drais partnered to form virtual company Tacurion to develop and commercialize Astellas' ASP7035 for nocturia. Tacurion...
...slated to start Phase II testing next quarter. Astellas, which has an option to acquire Tacurion...
...see BioCentury, April 30, 2012 & June 11, 2012). Drais Pharmaceuticals Inc. , Bridgewater, N.J. Tacurion Pharma Inc....
BioCentury | May 13, 2013
Financial News

Tacurion completes venture financing

Tacurion Pharma Inc. , Bridgewater, N.J. Business: Genitourinary Date completed: 5/7/13 Type: Venture financing Raised: $15 million Investors: InterWest Partners; Sutter Hill Ventures; Astellas Venture WIR Staff Genitourinary...
BioCentury | May 8, 2013
Company News

Astellas, Drais form newco to develop Astellas nocturia compound

...form a virtual company -- Tacurion Pharma Inc. -- to develop and commercialize Astellas' ASP7035 for nocturia. Tacurion...
...acquire Tacurion following the Phase II trial, is eligible for an undisclosed milestone, plus royalties. Tacurion...
Items per page:
1 - 5 of 5
BioCentury | May 23, 2016
Finance

Venturing west

...Potenza Therapeutics Inc. and autoimmune company Kanyos Bio Inc. Astellas spinouts include nocturia therapeutic developer Tacurion Pharma Inc....
BioCentury | Jun 17, 2013
Strategy

Externalizing Astellas

...spinouts of clinical assets. In May, Astellas and Drais Pharmaceuticals Inc. formed the virtual company Tacurion Pharma Inc....
...Inc. (NASDAQ:REGN), Tarrytown, N.J. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Seldar Pharma Inc. , Bridgewater, N.J. Tacurion Pharma Inc....
BioCentury | May 13, 2013
Company News

Drais, Tacurion, Astellas deal

...Drais partnered to form virtual company Tacurion to develop and commercialize Astellas' ASP7035 for nocturia. Tacurion...
...slated to start Phase II testing next quarter. Astellas, which has an option to acquire Tacurion...
...see BioCentury, April 30, 2012 & June 11, 2012). Drais Pharmaceuticals Inc. , Bridgewater, N.J. Tacurion Pharma Inc....
BioCentury | May 13, 2013
Financial News

Tacurion completes venture financing

Tacurion Pharma Inc. , Bridgewater, N.J. Business: Genitourinary Date completed: 5/7/13 Type: Venture financing Raised: $15 million Investors: InterWest Partners; Sutter Hill Ventures; Astellas Venture WIR Staff Genitourinary...
BioCentury | May 8, 2013
Company News

Astellas, Drais form newco to develop Astellas nocturia compound

...form a virtual company -- Tacurion Pharma Inc. -- to develop and commercialize Astellas' ASP7035 for nocturia. Tacurion...
...acquire Tacurion following the Phase II trial, is eligible for an undisclosed milestone, plus royalties. Tacurion...
Items per page:
1 - 5 of 5